Lockheed Martin Investment Management CO Biogen Inc. Transaction History

Lockheed Martin Investment Management CO

  • $1.43 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$257.52 - $306.91 $772,560 - $920,730
-3,000 Closed
0 $0
Q4 2017

Jan 18, 2018
BUY
$307.64 - $344.58 $307,640 - $344,580
1,000 Added 50.0%
3,000 $956,000
Q3 2017

Nov 06, 2017
BUY
$281.15 - $329.69 $562,300 - $659,380
2,000
2,000 $626,000

Others Institutions Holding BIIB

# of Institutions
1,047
Shares Held
126M
Call Options Held
1.37M
Put Options Held
1.35M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Lockheed Martin Investment Management CO Portfolio

Follow Lockheed Martin Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lockheed Martin Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Lockheed Martin Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email